Court of Appeals for the Eleventh Circuit September 6, 2002, 02-10151 (Pharmaceutical Research & Manufacturers of America v. Meadows)

Also known as

United States · · · 06-09-2002

[PUBLISH]

IN THE UNITED STATES COURT OF APPEALS

FOR THE ELEVENTH CIRCUIT

________________ FILED

U.S. COURT OF APPEALS

ELEVENTH CIRCUIT

No. 02-10151 September 6, 2002

________________ THOMAS K. KAHN

D. C. Docket No. 01-00356 CV-4-WS CLERK

PHARMACEUTICAL RESEARCH AND MANUFACTURERS

OF AMERICA,

Plaintiff-Appellant,

versus

RHONDA M. MEADOWS,

BOB SHARPE,

Deputy Secretary of Medicaid Agency for Health

Care Administration of the State of Florida,

Defendants-Appellees.

_______________________

Appeal from the United States District Court for the

Northern District of Florida

_______________________

(September 6, 2002)

Before BIRCH, MARCUS and CUDAHY*, Circuit Judges.

*

Honorable Richard D. Cudahy, U.S. Circuit Judge for the Seventh Circuit, sitting by designation.

CUDAHY, Circuit Judge:

The Florida legislature recently added another chapter in the ongoing efforts

of states to hold down their Medicaid drug costs. The new Florida law enacted

changes in its Medicaid program by creating a “preferred drug formulary” (also

referred to as a “preferred drug list”), which exempts certain Medicaid-eligible

drugs from a “prior authorization” requirement. If a drug is not on the preferred

list, the prescribing doctor must call a state pharmacist to obtain approval of its use.

In the course of this procedure, the pharmacist informs the doctor of the

availability of other drugs (usually on the preferred drug list) that allegedly have

comparable therapeutic value but are less expensive. The actual phone calls tend

to be relatively brief (usually less than 10 minutes in length), and approval of the

prescribing doctor’s first-choice drug is guaranteed in 100 percent of all cases,

provided only that he or she make the telephone call. During the first three months

of the program, approximately 55 percent of all these calls have resulted in a

change of the prescription to a drug on the preferred drug list.

Read the full text

This document is published by courtlistener.com.

Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.